drugset / Trial / NCT06915870
Comparison of Empagliflozin and Dapagliflozin in Patients With Heart Failure Taking Standard Treatment
RandomizedParallel-groupSingle-blindTreatment
Summary
Participants were enrolled and randomly divided in two groups. In group A, participants were prescribed Dapagliflozin 10 mg daily. In group B, participants were prescribed Empagliflozin 10 mg daily. All participants were followed-up in OPD after 12 weeks for assessment of ejection fraction.
Timeline
- Start
- 2024-07-12
- Primary completion
- 2025-01-13
- Completion
- 2025-01-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapagliflozin | Small molecule | 10 mg | — |
| Subject | Empagliflozin | Small molecule | 10 mg | — |